(HealthDay News) — Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures, ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to navenibart for the treatment of hereditary angioedema (HAE).

The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum glucocorticoid regulated kinase 1 (SGK1) inhibitor, for the treatment of long QT syndrome ...

The FDA is expected to decide on treatments for rosacea, AADC deficiency, breast cancer, transthyretin amyloid cardiomyopathy, and biliary tract cancer.

The US Department of Health and Human Services has set a goal that at least 95% of children in kindergarten get 2 doses of the measles-mumps-rubella (MMR) vaccine, a threshold that helps prevent ...

The alert follows an announcement from the US DOJ regarding the indictment of 18 individuals who operated a network of fake online pharmacies and pill mills.

Trastuzumab deruxtecan is a HER2-directed antibody and topoisomerase inhibitor conjugate currently marketed under the brand name Enhertu (fam-trastuzumab deruxtecan-nxki) for the treatment of breast ...

The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for sepiapterin as a treatment for pediatric and adult patients living with phenylketonuria (PKU).

Acalabrutinib, a Bruton tyrosine kinase inhibitor, is currently approved under the brand name Calquence ® for MCL in patients who have received at least 1 prior therapy. It is also indicated for the ...

The Food and Drug Administration (FDA) has granted Fast Track designation to zilganersen for the treatment of Alexander disease, a rare type of leukodystrophy.

(HealthDay News) — Harmful diagnostic errors (DEs) occur in an estimated one of every 14 hospitalized general medicine patients, according to a study published online Oct. 1 in BMJ Quality & Safety.